Skip to main content
. 2020 Jul 30;48(2):483–492. doi: 10.1007/s00259-020-04863-2

Table 3.

Diagnostic efficacies of csPCa detection by PSMA-TB and TRUS-GB in patients with different serum levels of PSA

PSA subgroups Patients csPCa(n) χ2 P
4 ~ 20 ng/ml 3.93 < 0.05
  PET Group (+) 9 8
(−) 28 2
  TRUS Group 34 3
20 ~ ng/ml 1.06 > 0.05
  PET Group (+) 16 14
(−) 7 0
  TRUS Group 26 12